DNA methylation changes in prostate cancer: current developments and future clinical implementation
MO Hoque - Expert review of molecular diagnostics, 2009 - Taylor & Francis
Promoter hypermethylation is associated with the loss of expression of tumor-suppressor
genes in cancer. Currently, several genome-wide technologies are available and have been …
genes in cancer. Currently, several genome-wide technologies are available and have been …
DNA methylation changes in prostate cancer: current developments and future clinical implementation
MO Hoque - Expert review of molecular diagnostics, 2009 - pubmed.ncbi.nlm.nih.gov
Promoter hypermethylation is associated with the loss of expression of tumor-suppressor
genes in cancer. Currently, several genome-wide technologies are available and have been …
genes in cancer. Currently, several genome-wide technologies are available and have been …
DNA methylation changes in prostate cancer: current developments and future clinical implementation
MO Hoque - Expert Review of Molecular Diagnostics, 2009 - search.proquest.com
Promoter hypermethylation is associated with the loss of expression of tumor-suppressor
genes in cancer. Currently, several genome-wide technologies are available and have been …
genes in cancer. Currently, several genome-wide technologies are available and have been …
[HTML][HTML] DNA methylation changes in prostate cancer: current developments and future clinical implementation
MO Hoque - Expert review of molecular diagnostics, 2009 - ncbi.nlm.nih.gov
Promoter hypermethylation is associated with loss of expression of tumor suppressor genes
in cancer. Currently, several genome-wide technologies are available and have been …
in cancer. Currently, several genome-wide technologies are available and have been …
DNA methylation changes in prostate cancer: current developments and future clinical implementation.
MO Hoque - Expert Review of Molecular Diagnostics, 2009 - europepmc.org
Promoter hypermethylation is associated with loss of expression of tumor suppressor genes
in cancer. Currently, several genome-wide technologies are available and have been …
in cancer. Currently, several genome-wide technologies are available and have been …
DNA methylation changes in prostate cancer: current developments and future clinical implementation
MO Hoque - Expert Review of Molecular Diagnostics, 2009 - go.gale.com
The successful completion of the Human Genome Project has resulted in the annotation of
approximately 30,000 genes. The major key question facing the scientific and clinical …
approximately 30,000 genes. The major key question facing the scientific and clinical …
DNA methylation changes in prostate cancer: Current developments and future clinical implementation
MO Hoque - Expert Review of Molecular Diagnostics, 2009 - pure.johnshopkins.edu
Promoter hypermethylation is associated with the loss of expression of tumor-suppressor
genes in cancer. Currently, several genome-wide technologies are available and have been …
genes in cancer. Currently, several genome-wide technologies are available and have been …
DNA methylation changes in prostate cancer: current developments and future clinical implementation.
MO Hoque - Expert Review of Molecular Diagnostics, 2009 - europepmc.org
Promoter hypermethylation is associated with loss of expression of tumor suppressor genes
in cancer. Currently, several genome-wide technologies are available and have been …
in cancer. Currently, several genome-wide technologies are available and have been …